Literature DB >> 11753193

Severe intoxication from xylazine inhalation.

A J Capraro1, J F Wiley, J R Tucker.   

Abstract

We present the first documented case of overdose from xylazine inhalation. The patient developed findings consistent with alpha 2 adrenergic agonist toxicity, eg coma, miosis, apnea, bradycardia, hypothermia, and dry mouth 2 hours after exposure. Standard dose naloxone did not reverse these effects. The patient fully recovered after appropriate supportive measures. A review of prior reports of xylazine exposure is provided.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11753193     DOI: 10.1097/00006565-200112000-00012

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  5 in total

1.  Xylazine (veterinary sedative) use in Puerto Rico.

Authors:  Rafael A Torruella
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-04-11

2.  The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico.

Authors:  J C Reyes; J L Negrón; H M Colón; A M Padilla; M Y Millán; T D Matos; R R Robles
Journal:  J Urban Health       Date:  2012-06       Impact factor: 3.671

3.  GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles.

Authors:  Nayra Rodríguez; José Vargas Vidot; Juan Panelli; Héctor Colón; Bob Ritchie; Yasuhiro Yamamura
Journal:  Drug Alcohol Depend       Date:  2008-05-09       Impact factor: 4.492

4.  Effects of combined ketamine/xylazine anesthesia on light induced retinal degeneration in rats.

Authors:  Blanca Arango-Gonzalez; Andreas Schatz; Sylvia Bolz; Javier Eslava-Schmalbach; Gabriel Willmann; Ahmad Zhour; Eberhart Zrenner; M Dominik Fischer; Florian Gekeler
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

5.  Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys.

Authors:  Yong-Fu Xiao; Bingdi Wang; Xiaoli Wang; Fenglai Du; Michael Benzinou; Yi-Xin Jim Wang
Journal:  BMC Anesthesiol       Date:  2013-10-20       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.